Nova Leap Health Stock Buy Hold or Sell Recommendation
| NLH Stock | CAD 0.25 0.01 3.85% |
Assuming the 90 days horizon and your above-average risk tolerance, our recommendation regarding Nova Leap Health is 'Strong Sell'. A buy or sell recommendation provided by Macroaxis is an automated directive regarding whether to purchase or sell Nova Leap Health given historical horizon and risk tolerance towards Nova Leap. When Macroaxis issues a 'buy' or 'sell' recommendation for Nova Leap Health, the advice is generated through an automated system that utilizes algorithms and statistical models.
Check out Nova Leap Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. Note, we conduct extensive research on individual companies such as Nova and provide practical buy, sell, or hold advice based on investors' constraints. Nova Leap Health. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.
Nova |
Execute Nova Leap Buy or Sell Advice
The Nova recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on Nova Leap Health. Macroaxis does not own or have any residual interests in Nova Leap Health or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute Nova Leap's advice using the current market data and latest reported fundamentals.
Time Horizon
Risk Tolerance
 |  |
Strong Sell
Market Performance | Very Weak | Details | |
Volatility | Out of control | Details | |
Hype Condition | Stale | Details | |
Current Valuation | Overvalued | Details | |
Odds Of Distress | Below Average | Details | |
Economic Sensitivity | Barely shadows the market | Details | |
Analyst Consensus | Not Available | Details | |
Reporting Quality (M-Score) | Inapplicable | Details |
Nova Leap Trading Alerts and Improvement Suggestions
| Nova Leap Health has some characteristics of a very speculative penny stock | |
| Nova Leap Health had very high historical volatility over the last 90 days | |
| The company has C$3.97 Million in debt which may indicate that it relies heavily on debt financing | |
| Nova Leap Health has accumulated 3.97 M in total debt with debt to equity ratio (D/E) of 64.8, indicating the company may have difficulties to generate enough cash to satisfy its financial obligations. Nova Leap Health has a current ratio of 0.57, indicating that it has a negative working capital and may not be able to pay financial obligations in time and when they become due. Debt can assist Nova Leap until it has trouble settling it off, either with new capital or with free cash flow. So, Nova Leap's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Nova Leap Health sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Nova to invest in growth at high rates of return. When we think about Nova Leap's use of debt, we should always consider it together with cash and equity. | |
| The entity reported the revenue of 26.41 M. Net Loss for the year was (1.07 M) with profit before overhead, payroll, taxes, and interest of 9.98 M. | |
| About 41.0% of Nova Leap outstanding shares are owned by corporate insiders | |
| Latest headline from news.google.com: Nova Leap Health Corp. entered into an agreement to acquire Earth Angels Living Assistance Inc.Earth Angels South Shore Inc. for CAD 1.38 million. - Marketscreener.com |
Nova Leap Returns Distribution Density
The distribution of Nova Leap's historical returns is an attempt to chart the uncertainty of Nova Leap's future price movements. The chart of the probability distribution of Nova Leap daily returns describes the distribution of returns around its average expected value. We use Nova Leap Health price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of Nova Leap returns is essential to provide solid investment advice for Nova Leap.
| Mean Return | -0.04 | Value At Risk | -6.9 | Potential Upside | 7.14 | Standard Deviation | 3.82 |
Return Density |
| Distribution |
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of Nova Leap historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.
Nova Leap Cash Flow Accounts
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Change In Cash | 351.7K | 1.1M | (1.0M) | (460.8K) | (1.1M) | (1.0M) | |
| Net Borrowings | 466.9K | (826.6K) | 189.0K | (2.9M) | (2.6M) | (2.5M) | |
| Depreciation | 618.7K | 544.2K | 861.5K | 1.4M | 1.0M | 595.0K | |
| Net Income | (1.1M) | 1.3M | 1.8M | (835.7K) | (1.1M) | (1.0M) | |
| Change To Netincome | 1.1M | 563.3K | 154.0K | 611.0K | 702.6K | 359.6K | |
| Free Cash Flow | 598.3K | 3.0M | 2.2M | 949.5K | 1.4M | 766.1K | |
| Other Non Cash Items | 669.9K | 1.4M | 1.0M | (240.5K) | 254.2K | 426.5K | |
| End Period Cash Flow | 1.6M | 2.8M | 1.7M | 1.3M | 1.1M | 1.4M | |
| Investments | (993.5K) | (1.6M) | (7.4M) | (56.2K) | (31.8K) | (33.4K) |
Nova Leap Greeks
Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to Nova Leap or Health Care Providers & Services sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that Nova Leap's price will be affected by overall stock market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a Nova stock's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
α | Alpha over Dow Jones | -0.08 | |
β | Beta against Dow Jones | 0.19 | |
σ | Overall volatility | 3.69 | |
Ir | Information ratio | -0.05 |
Nova Leap Volatility Alert
Nova Leap Health exhibits very low volatility with skewness of 0.11 and kurtosis of 0.34. Nova Leap Health is a potential penny stock. Although Nova Leap may be in fact a good instrument to invest, many penny stocks are speculative in nature and are subject to artificial price hype. Please make sure you totally understand the upside potential and downside risk of investing in Nova Leap Health. We encourage investors to look for signals such as email spams, message board hypes, claims of breakthroughs, volume upswings, sudden news releases, promotions that are not reported, or demotions released before SEC filings. Please also check biographies and work history of current and past company officers before investing in high volatility instruments, penny stocks, or equities with microcap classification. You can indeed make money on Nova instrument if you perfectly time your entry and exit. However, remember that penny stocks that have been the subject of artificial hype usually unable to maintain their increased share price for more than just a few days. The price of a promoted high volatility instrument will almost always revert back. The only way to increase shareholder value is through legitimate performance backed up by solid fundamentals.Nova Leap Fundamentals Vs Peers
Comparing Nova Leap's fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze Nova Leap's direct or indirect competition across all of the common fundamentals between Nova Leap and the related equities. This way, we can detect undervalued stocks with similar characteristics as Nova Leap or determine the stocks which would be an excellent addition to an existing portfolio. Peer analysis of Nova Leap's fundamental indicators could also be used in its relative valuation, which is a method of valuing Nova Leap by comparing valuation metrics with those of similar companies.
| Better Than Average | Worse Than Average | Compare Nova Leap to competition |
| Fundamentals | Nova Leap | Peer Average |
| Return On Equity | -0.0249 | -0.31 |
| Return On Asset | 0.0279 | -0.14 |
| Profit Margin | (0.02) % | (1.27) % |
| Operating Margin | 0.03 % | (5.51) % |
| Current Valuation | 21.31 M | 16.62 B |
| Shares Outstanding | 86.21 M | 571.82 M |
| Shares Owned By Insiders | 40.76 % | 10.09 % |
| Number Of Shares Shorted | 12.7 K | 4.71 M |
| Price To Book | 0.84 X | 9.51 X |
| Price To Sales | 0.84 X | 11.42 X |
| Revenue | 26.41 M | 9.43 B |
| Gross Profit | 9.98 M | 27.38 B |
| EBITDA | 1.23 M | 3.9 B |
| Net Income | (1.07 M) | 570.98 M |
| Cash And Equivalents | 1.24 M | 2.7 B |
| Cash Per Share | 0.02 X | 5.01 X |
| Total Debt | 3.97 M | 5.32 B |
| Debt To Equity | 64.80 % | 48.70 % |
| Current Ratio | 0.58 X | 2.16 X |
| Book Value Per Share | 0.21 X | 1.93 K |
| Cash Flow From Operations | 1.41 M | 971.22 M |
| Short Ratio | 0.72 X | 4.00 X |
| Earnings Per Share | (0.02) X | 3.12 X |
| Target Price | 0.6 | |
| Beta | 1.52 | -0.15 |
| Market Capitalization | 23.28 M | 19.03 B |
| Total Asset | 23.95 M | 29.47 B |
| Retained Earnings | (1.19 M) | 9.33 B |
| Working Capital | (10.37 K) | 1.48 B |
| Net Asset | 23.95 M |
Nova Leap Market Momentum
Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as Nova . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
About Nova Leap Buy or Sell Advice
When is the right time to buy or sell Nova Leap Health? Buying financial instruments such as Nova Stock isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.
Use Investing Ideas to Build Portfolios
In addition to having Nova Leap in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Large & Mid Caps ETFs Thematic Idea Now
Large & Mid Caps ETFs
ETF themes focus on helping investors to gain exposure to a broad range of assets, diversify, and lower overall costs. The Large & Mid Caps ETFs theme has 41 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Large & Mid Caps ETFs Theme or any other thematic opportunities.
| View All Next | Launch |
Additional Tools for Nova Stock Analysis
When running Nova Leap's price analysis, check to measure Nova Leap's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Nova Leap is operating at the current time. Most of Nova Leap's value examination focuses on studying past and present price action to predict the probability of Nova Leap's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Nova Leap's price. Additionally, you may evaluate how the addition of Nova Leap to your portfolios can decrease your overall portfolio volatility.